A CONSORTIUM TO STUDY THE GENETICS OF LONGEVITY

$70,816U19FY2015AGNIH

California Pacific Med Ctr Res Institute, San Francisco CA

Investigators

Linked publications & trials

Paper 39514576 Paper 39504246 Paper 39479990 Paper 39471117 Paper 39442081 Paper 39314370 Paper 39193565 Paper 39131277 Paper 39108483 Paper 38995775 Paper 38932496 Paper 38833463 Paper 38773714 Paper 38745705 Paper 38645061 Paper 38617340 Paper 38451433 Paper 38370654 Paper 38232391 Paper 38200295 Paper 38200294 Paper 38197533 Paper 38114855 Paper 38045352 Paper 38036780 Paper 37986748 Paper 37694163 Paper 37669771 Paper 37661888 Paper 37653270 Paper 37582244 Paper 37572790 Paper 37481675 Paper 37418003 Paper 37315291 Paper 37294184 Paper 37273159 Paper 37255593 Paper 37205553 Paper 37165176 Paper 37032736 Paper 37005201 Paper 36988570 Paper 36941332 Paper 36920743 Paper 36909644 Paper 36909609 Paper 36824828 Paper 36810715 Paper 36806354 Paper 36802395 Paper 36693629 Paper 36648445 Paper 36626722 Paper 36613555 Paper 36598107 Paper 36389222 Paper 36370099 Paper 36357685 Paper 36342748 Paper 36335489 Paper 36331340 Paper 36318223 Paper 36316462 Paper 36212134 Paper 36074795 Paper 36010592 Paper 35997888 Paper 35831657 Paper 35690059 Paper 35613471 Paper 35466328 Paper 35418183 Paper 35413975 Paper 35290070 Paper 35184559 Paper 35119614 Paper 35104566 Paper 34962809 Paper 34943957 Paper 34672606 Paper 34654818 Paper 34593707 Paper 34309657 Paper 34226941 Paper 34210964 Paper 33988501 Paper 33948810 Paper 33838015 Paper 33771926 Paper 33742521 Paper 33731896 Paper 33711481 Paper 33650986 Paper 33619379 Paper 33529024 Paper 33512769 Paper 33511361 Paper 33488674 Paper 33299186

Abstract

We have strengthened our revised proposal in several major ways. First, we have expanded our genetic sequencing of the extreme phenotype of centenarians (with appropriate controls) to include the entire human exome, in addition to regulatory/conserved regions of more genes (~1,000) selected by our Scientific Advisory Committee, based on work from model systems and previous genome-wide association studies (GWAS) for longevity. Second, instead of creating a Gene Function Core, we will analyze and characterize in silico the variants we discover in order to identify the best candidates for subsequent functional studies. Third, after careful consideration of reviewers' comments and concerns about the proposed in vitro work, we decided to defer several proposals for in vitro studies of specific pathways-insulin signaling, TOR, mitochondria and energy-sensing, micro- and regulatory RNA, and proteostasis?until we have identified the best candidates for functional studies. In addition, we have modified the remaining projects and cores in response to the previous reviews. We are excited that the next phase of the Longevity Consortium (LC) will have a substantial impact on research on aging and chronic degenerative diseases.

View original record on NIH RePORTER →